Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT06981286
Starting soon Observational

Oral Health Parameter-Based Diabetes Type 2 Indication Using Machine Learning

NCT06981286 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2025-08-30
Last updated
2025-05-20

Condition(s) studied

Type 2 Diabetes

Investigational drug(s) / intervention(s)

A dataset comprising participants withT2D will be used to evaluate the classification performance of various machine learning techniques.

A dataset comprising participants withT2D will be used to evaluate the classification performance of various machine learning techniques.: A dataset comprising participants with T2D will be used to evaluate the classification performance of various machine-learning techniques.

Study summary

This study aims to explore the potential of using machine learning (ML) algorithms to predict Diabetes type2, based on oral health and demographic data. The objective is to evaluate the effectiveness of various ML models and identify the most relevant oral health indicators for predicting type 2 diabetes in individuals with mild cognitive impairment aged 60 and above.

Eligibility

Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Individuals aged 60 years or older. * Participants with recorded oral health parameters with or without Diabetes type2 Exclusion Criteria: • Individuals with Diabetes type1

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Health, Blekinge Institute of Technology Karlskrona Sweden

More Blekinge Institute of Technology trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06981286 on ClinicalTrials.gov ↗ ← All trials in Sweden